{"gene":"JCHAIN","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":2024,"finding":"J-chain (JC) outcompetes the sixth IgM subunit during assembly of IgM pentamers. Before insertion into IgM, JC exists as largely unstructured, protease-sensitive species with heterogeneous non-native disulfide bonds. JC interacts with hydrophobic β-sheets selectively exposed by nascent pentamers, and completion of an amyloid-like core triggers JC folding and drives disulfide rearrangements that covalently stabilize JC-containing pentamers. The quality control factor ERp44 surveys IgM assembly and prevents secretion of aberrant conformers.","method":"In vitro reconstitution, in cellula assembly assays, protease sensitivity assays, disulfide bond analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution combined with in cellula validation and multiple orthogonal biochemical methods in a single rigorous study","pmids":["39632981"],"is_preprint":false},{"year":1993,"finding":"The Ets-related transcription factor PU.1 is the nuclear protein (NF-JB) that mediates positive regulatory activity of the JB element in the J-chain promoter. PU.1 binds the JB site despite it lacking the canonical GGA Ets core, and a glutamine-rich sequence in the amino-terminal portion of PU.1 is required for transcriptional activation. A dominant negative PU.1 mutant suppresses transcriptional activity of a 1.2-kb J-chain promoter.","method":"Protein purification, DNA-binding characterization, transient transfection reporter assays, dominant-negative mutagenesis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — protein purification, functional mutagenesis, and reporter assays with multiple orthogonal methods in one study","pmids":["8406004"],"is_preprint":false},{"year":1992,"finding":"A bifunctional promoter element (JB, located between -75 and -45) in the J-chain gene acts as a repressor in J-chain-silent B cells and as an activator in J-chain-expressing cells. IL-2 signaling triggers the activator function of JB through a B-cell-specific nuclear protein NF-JB, making JB the likely target of the IL-2 signal.","method":"Deletion analysis of 5' flanking region, nuclear factor binding assays, transient transfection reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion mapping and factor binding combined, single lab, two orthogonal methods","pmids":["1631082"],"is_preprint":false},{"year":1991,"finding":"IL-2 and IL-5 each trigger a decrease in binding of two promoter-specific nuclear repressor proteins to the J-chain promoter, preceding the appearance of J-chain RNA. The two lymphokines act additively, their effects are reversed upon withdrawal, and both are inhibited by IL-4, indicating the IL-2 and IL-5 signal pathways converge to regulate repressor activities of J-chain promoter elements.","method":"Inducible β-lymphoma cell line, J-chain RNA expression analysis, nuclear factor binding assays, lymphokine withdrawal and IL-4 inhibition experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA expression and factor binding assays, single lab, two orthogonal methods","pmids":["1763018"],"is_preprint":false},{"year":1986,"finding":"Activation of the J-chain gene during B-cell differentiation to IgM-secreting cells is associated with chromatin remodeling at the 5' end of the gene: a 240-bp region is nuclease-resistant in immature B cells, becomes slightly more accessible in mature B cells, and displays an open DNase I-hypersensitive structure in IgM-secreting cells. This open structure is coinducible with J-chain gene expression in mitogen-stimulated lymphocytes.","method":"Nuclease sensitivity/DNase I hypersensitivity assays in lymphoid cell lines and mitogen-stimulated lymphocytes","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chromatin accessibility assay combined with expression correlation, single lab","pmids":["3025626"],"is_preprint":false},{"year":2006,"finding":"Stage-specific expression of the IgJ gene in plasma cells is regulated by chromatin accessibility and histone acetylation: hypersensitive site 1 on the IgJ promoter opens in plasma cells, and H3 and H4 histones at the IgJ gene chromatin are hyperacetylated in plasma cells but not in pre-B cells. IL-2 treatment of the BCL1 model cell line induces hyperacetylation of H3 and H4 at the IgJ gene chromatin.","method":"DNase I hypersensitivity mapping, chromatin immunoprecipitation for histone acetylation, IL-2 stimulation of BCL1 cells","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chromatin accessibility and ChIP assays, single lab, two orthogonal methods","pmids":["17015728"],"is_preprint":false},{"year":2023,"finding":"The N459-glycan on the IgA1-Fc tailpiece is essential for dimer formation in the presence of J-chain (N459Q mutant fails to form proper dimer and instead generates higher-order aggregates). The N49-glycan on J-chain and the N263-glycan on IgA1-Fc both contribute to thermal stability of the Fc–J-chain complex. Fluorescence experiments indicate the N459-glycans cover a hydrophobic surface that prevents excess Fc molecules from approaching the dimeric IgA.","method":"Site-directed mutagenesis of N-glycosylation sites, mass spectrometry, fluorescence assays, thermofluor (thermal shift) assay, NMR of 13C-labeled Fc","journal":"Biochimica et biophysica acta. General subjects","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis, mass spectrometry, NMR, and functional thermal assays in one study, multiple orthogonal methods","pmids":["38070292"],"is_preprint":false},{"year":1983,"finding":"J-chain in IgA- and IgM-producing cells is substantially incorporated into polymeric Ig complexes at the cytoplasmic level; acid-urea pretreatment enhances J-chain staining, indicating molecular unfolding exposes concealed J-chains. The completed polymers bind secretory component (SC) in vitro via specific non-covalent forces at the cytoplasm of J-chain-positive IgA and IgM cells. IgM cells exhibit stronger SC binding than IgA cells. IgG and IgD cells do not generally express affinity for SC.","method":"Immunohistochemistry with acid-urea pretreatment, in vitro SC binding to tissue sections","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — IHC with functional SC-binding assay, replicated across multiple tissue types in one study","pmids":["6417474"],"is_preprint":false},{"year":1983,"finding":"In lymphoblastoid cell lines, J-chain is present in disulfide-linked form in IgM and IgA producers but in free (non-disulfide-linked) form in IgG cells; intracellular J-chain is not disulfide-linked to IgG in IgG/J-chain-producing cells. In PWM-stimulated PBL, J-chain is secreted only in disulfide-linked form associated with polymeric Ig and not as a free form. Subcellular fractionation showed J-chain and Ig associate with fractions containing ribosomes, cell sap, and low molecular weight RNA.","method":"Immunoprecipitation, immunofluorescence, RIA, subcellular fractionation, biosynthetic labeling","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical methods (fractionation, immunoprecipitation, biosynthetic labeling), single lab","pmids":["6417475"],"is_preprint":false},{"year":1976,"finding":"Structural analysis of a human Fc5μ-like fragment showed that J-chain is covalently linked as a 'clasp' within a single IgM subunit (within the 95 kDa subunit) and not between two subunits, as determined by partial reduction, alkylation, and peptide sequence analysis.","method":"Partial reduction and alkylation, SDS-PAGE, peptide structural analysis","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct biochemical structural determination but single study with limited follow-up in the corpus","pmids":["821533"],"is_preprint":false},{"year":2007,"finding":"J-chain protein is expressed in a subset of CD11c+ dendritic cells (DC) in mice. J-chain knockout mice have reduced fractions of CD4-/CD8α+ and mPDCA-1+ DC in the spleen, reduced IDO RNA in spleen, fewer IDO-expressing cells in lymph nodes, reduced IDO protein in splenic CD11c+ cells, lower serum kynurenine/tryptophan ratio (indicating reduced IDO activity), and are less susceptible to tolerance induction.","method":"Flow cytometry, J-chain knockout mice, IDO RNA and protein quantification, serum kynurenine/tryptophan ratio measurement, tolerance induction assays","journal":"Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — J-chain KO mouse with multiple functional readouts, single lab","pmids":["18028376"],"is_preprint":false},{"year":2006,"finding":"J-chain-deficient mice show normal primary IgG responses but compromised secondary IgG responses and reduced B cell repertoire switching from lambda to kappa. Adoptive transfer experiments demonstrated that the compromised secondary immune response is transferred with T cells from J-/- mice, establishing that J-chain deficiency causes a selective defect in T helper cell function that impairs B cell memory formation.","method":"J-chain knockout mice, immunization with NP-hapten, serum IgG measurement, B cell repertoire analysis, adoptive transfer experiments","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with adoptive transfer providing pathway placement, single lab","pmids":["16688681"],"is_preprint":false},{"year":2005,"finding":"A Stat5-overlapping sequence in the IgJ enhancer is essential for enhancer function in plasma cells and is bound by a ubiquitous protein (not Stat5 or other tested Stat family members, <52 kDa), as identified by in vivo footprinting and EMSA. The opened chromatin of the IgJ enhancer is maintained in plasma cells even in the absence of IL-2/Stat5 signaling.","method":"In vivo footprinting, EMSA with competitors and antibodies, UV-crosslinking/SDS-PAGE, reporter assays","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — EMSA and in vivo footprint, identity of binding protein not determined, single lab","pmids":["16288984"],"is_preprint":false},{"year":2006,"finding":"The HSS3/4 enhancer of the Crlz1-IgJ locus is bound by EBF (early B cell factor) specifically in pre-B cells, as shown by EMSA with oligo-DNA competitors, anti-EBF antibodies, and mutational analysis demonstrating that mutations within the EBF site impair HSS3/4 enhancer activity in pre-B cells but not in plasma cells.","method":"EMSA with competitors and anti-EBF antibodies, in vivo footprinting, enhancer reporter assay with EBF-site mutations","journal":"Immunology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA with antibody supershift and mutagenesis, two orthogonal methods, single lab","pmids":["16962668"],"is_preprint":false},{"year":2023,"finding":"IGJ overexpression in breast cancer cells suppresses proliferation, invasion, and metastasis in vivo and in vitro by inhibiting epithelial-to-mesenchymal transition (EMT) and suppressing nuclear translocation of p65 (NF-κB). Rescue experiments confirmed that IGJ restricts breast cancer cell proliferation and metastasis via the NF-κB signaling pathway.","method":"CCK-8 assay, invasion/migration assays, scratch tests, in vivo xenograft, western blot, immunofluorescence for p65 nuclear translocation, GSEA/KEGG analysis, rescue experiments","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — gain-of-function with multiple cellular readouts and pathway rescue, single lab","pmids":["37539706"],"is_preprint":false},{"year":2024,"finding":"IGJ knockdown in rheumatoid arthritis fibroblast-like synoviocytes (MH7A cells) inhibits cell growth, suppresses inflammatory response, and blocks cell motility. Mechanistically, IGJ knockdown suppresses the NF-κB signaling axis in these cells.","method":"CCK-8 and flow cytometry for growth, ELISA and immunoblot for inflammation, transwell assay for motility, immunoblot for NF-κB pathway components","journal":"International journal of rheumatic diseases","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, loss-of-function in a non-B-cell context with pathway inference by western blot only","pmids":["39091178"],"is_preprint":false},{"year":2025,"finding":"IGJ overexpression in NALM-6 B-ALL cells via CRISPRa leads to increased metabolic activity and confers resistance to dexamethasone, cytarabine, doxorubicin, and methotrexate but not cyclophosphamide, suggesting IGJ promotes metabolic reprogramming contributing to chemoresistance.","method":"CRISPRa-mediated IGJ overexpression, Seahorse XF metabolic assays, resazurin-based chemoresistance viability assays","journal":"Pediatric blood & cancer","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single gain-of-function experiment in a cell line, no pathway mechanism defined, single lab","pmids":["41048199"],"is_preprint":false},{"year":1988,"finding":"J-chain expression during plasma cell differentiation is independent of immunoglobulin gene rearrangement status. EBV-transformed immunoglobulin-negative precursor B cells with no detectable Ig gene rearrangements still generate subpopulations producing high levels of J-chain, with J-chain production confined to cells that have exited the cell cycle to undergo plasma-cell differentiation.","method":"Immunoprecipitation after biosynthetic labeling, Northern blot hybridization, immunofluorescence, surface antigen analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (immunoprecipitation, Northern blot, immunofluorescence) in single lab study","pmids":["2829207"],"is_preprint":false}],"current_model":"JCHAIN encodes a ~15 kDa polypeptide that is incorporated into IgA dimers and IgM pentamers via disulfide bonds with the C-terminal tailpiece of α- or μ-heavy chains; mechanistically, it outcompetes the sixth IgM subunit during assembly by folding upon interaction with hydrophobic β-sheets of nascent pentamers and driving disulfide rearrangements, a process surveyed by ERp44; N-glycosylation of the IgA tailpiece (N459) and J-chain (N49) are required for proper dimer formation and complex stability; transcription of the JCHAIN gene is activated during B-cell differentiation by chromatin remodeling, histone hyperacetylation, and IL-2/IL-5 signaling acting through the JB promoter element whose positive activator is the Ets-family factor PU.1; beyond its immunoglobulin-assembly role, J-chain is expressed in a subset of immunoregulatory dendritic cells where it supports IDO activity and immune tolerance, and J-chain deficiency impairs T helper cell function and B-cell memory."},"narrative":{"mechanistic_narrative":"JCHAIN encodes a small polypeptide that is incorporated into polymeric immunoglobulins, where it functions as an assembly factor that templates and stabilizes IgM pentamers and IgA dimers [PMID:39632981, PMID:38070292]. Mechanistically, J-chain begins as a largely unstructured, protease-sensitive species carrying heterogeneous non-native disulfide bonds; it engages hydrophobic β-sheets selectively exposed on nascent IgM pentamers, and completion of an amyloid-like core triggers J-chain folding and drives the disulfide rearrangements that covalently lock it into the polymer in place of a sixth IgM subunit, a process surveyed by the quality-control factor ERp44 [PMID:39632981]. Within IgM it is linked as a covalent 'clasp' inside a single subunit rather than bridging two subunits [PMID:821533], and it is incorporated only in disulfide-linked form in IgM- and IgA-producing cells while remaining free in IgG cells [PMID:6417475]. N-glycosylation governs this assembly: the IgA1-Fc tailpiece N459-glycan is required for proper dimer formation and shields a hydrophobic surface that excludes excess Fc, while the J-chain N49- and Fc N263-glycans contribute thermal stability to the complex [PMID:38070292]. Completed J-chain-containing polymers acquire the capacity to bind secretory component non-covalently, a property restricted to IgA and IgM cells [PMID:6417474]. Transcription of JCHAIN is induced during terminal B-cell/plasma-cell differentiation, independent of immunoglobulin gene rearrangement [PMID:2829207], through chromatin opening and histone H3/H4 hyperacetylation at the promoter [PMID:3025626, PMID:17015728] and through the bifunctional JB promoter element, whose IL-2/IL-5-driven activator function is mediated by the Ets-family factor PU.1 [PMID:8406004, PMID:1631082, PMID:1763018]. Beyond immunoglobulin assembly, J-chain is expressed in a subset of CD11c+ dendritic cells where it supports IDO activity and tolerance induction [PMID:18028376], and J-chain deficiency selectively impairs T helper cell function and secondary IgG/B-cell memory responses [PMID:16688681].","teleology":[{"year":1976,"claim":"Established the topology of J-chain within polymeric Ig by determining that it is covalently clasped inside a single IgM subunit rather than bridging adjacent subunits, constraining models of how J-chain organizes pentamer assembly.","evidence":"Partial reduction/alkylation and peptide structural analysis of a human Fc5μ-like fragment","pmids":["821533"],"confidence":"Medium","gaps":["Did not resolve how J-chain selects its insertion site during assembly","Single structural study with limited follow-up"]},{"year":1983,"claim":"Defined the assembly-state specificity of J-chain by showing it is disulfide-linked and secreted only with polymeric IgM/IgA and remains free in IgG cells, and that completed polymers acquire secretory-component binding.","evidence":"Immunoprecipitation, biosynthetic labeling, subcellular fractionation, and in vitro SC-binding to tissue sections","pmids":["6417474","6417475"],"confidence":"Medium","gaps":["Mechanism distinguishing IgM/IgA from IgG incorporation not defined","SC-binding assayed on tissue sections rather than purified components"]},{"year":1986,"claim":"Linked J-chain induction to chromatin remodeling by showing a 5' region transitions from nuclease-resistant in immature B cells to DNase I-hypersensitive in IgM-secreting cells, coinducible with expression.","evidence":"Nuclease/DNase I hypersensitivity assays in lymphoid lines and mitogen-stimulated lymphocytes","pmids":["3025626"],"confidence":"Medium","gaps":["Did not identify the trans-acting factors driving chromatin opening","Correlative rather than causal link to expression"]},{"year":1988,"claim":"Decoupled J-chain transcription from immunoglobulin gene rearrangement, showing that Ig-negative precursors lacking detectable rearrangements still produce high J-chain levels upon plasma-cell differentiation.","evidence":"Biosynthetic labeling/immunoprecipitation, Northern blot, immunofluorescence in EBV-transformed precursor B cells","pmids":["2829207"],"confidence":"Medium","gaps":["Did not define the differentiation signal triggering expression","Restricted to EBV-transformed lines"]},{"year":1992,"claim":"Identified the bifunctional JB promoter element as a repressor in silent cells and activator in expressing cells, and placed it downstream of IL-2 signaling via a B-cell-specific factor.","evidence":"Deletion mapping, nuclear factor binding, and reporter assays","pmids":["1631082"],"confidence":"Medium","gaps":["Molecular identity of NF-JB not yet established","Single-lab promoter dissection"]},{"year":1993,"claim":"Identified PU.1 as the NF-JB activator of the J-chain promoter, showing it binds the non-canonical JB site and that its glutamine-rich region and dominant-negative mutants control transcriptional output.","evidence":"Protein purification, DNA-binding characterization, reporter assays, dominant-negative mutagenesis","pmids":["8406004"],"confidence":"High","gaps":["Did not explain how PU.1 switches the element between repressor and activator modes","Cofactors required for activation not defined"]},{"year":2006,"claim":"Connected stage-specific J-chain expression to histone hyperacetylation, showing H3/H4 acetylation and hypersensitive site opening occur in plasma cells and are inducible by IL-2.","evidence":"DNase I hypersensitivity mapping, ChIP for histone acetylation, IL-2 stimulation of BCL1 cells","pmids":["17015728"],"confidence":"Medium","gaps":["Acetyltransferases responsible not identified","Causality between acetylation and transcription not directly tested"]},{"year":2006,"claim":"Revealed non-immunoglobulin roles for J-chain in immunity, showing J-chain deficiency selectively impairs T helper function and secondary IgG memory responses via a T-cell-intrinsic defect.","evidence":"J-chain knockout mice, NP-hapten immunization, repertoire analysis, adoptive transfer","pmids":["16688681"],"confidence":"Medium","gaps":["Molecular basis of the T-cell defect unknown","Single-lab KO phenotype"]},{"year":2006,"claim":"Extended the regulatory map by identifying EBF binding at the HSS3/4 enhancer specifically in pre-B cells, with EBF-site mutations impairing enhancer activity in that stage.","evidence":"EMSA with anti-EBF supershift, in vivo footprinting, enhancer reporter mutagenesis","pmids":["16962668"],"confidence":"Medium","gaps":["Functional role of pre-B-cell enhancer activity in mature expression unclear"]},{"year":2007,"claim":"Demonstrated a tolerogenic role for J-chain in dendritic cells, showing J-chain KO mice have reduced IDO-expressing DC subsets, lower IDO activity, and impaired tolerance induction.","evidence":"Flow cytometry, IDO RNA/protein quantification, serum kynurenine/tryptophan ratio, tolerance assays in J-chain KO mice","pmids":["18028376"],"confidence":"Medium","gaps":["Direct molecular link between J-chain and IDO regulation not established","Mechanism of J-chain action in DC unknown"]},{"year":2023,"claim":"Defined the glycan requirements for IgA dimer assembly, showing the Fc tailpiece N459-glycan is essential for proper dimerization and shields a hydrophobic surface that excludes excess Fc, with J-chain N49 and Fc N263 glycans stabilizing the complex.","evidence":"Site-directed mutagenesis, mass spectrometry, fluorescence, thermal shift, and NMR","pmids":["38070292"],"confidence":"High","gaps":["Glycan contribution to IgM pentamer assembly not addressed","In vivo relevance of aggregate formation untested"]},{"year":2024,"claim":"Resolved the mechanism of J-chain incorporation into IgM, showing unstructured J-chain folds upon engaging hydrophobic β-sheets of nascent pentamers, completes an amyloid-like core, drives disulfide rearrangements, and outcompetes a sixth subunit under ERp44 surveillance.","evidence":"In vitro reconstitution, in cellula assembly assays, protease-sensitivity and disulfide analysis","pmids":["39632981"],"confidence":"High","gaps":["Structural model of the folded J-chain/pentamer interface not fully defined","How ERp44 distinguishes correct from aberrant conformers not detailed"]},{"year":2023,"claim":"Proposed a tumor-suppressive function for IGJ in breast cancer, where overexpression inhibits proliferation, invasion, EMT, and metastasis by blocking p65/NF-κB nuclear translocation.","evidence":"Proliferation/invasion assays, xenografts, western blot, p65 immunofluorescence, and rescue experiments","pmids":["37539706"],"confidence":"Medium","gaps":["Direct molecular interaction between IGJ and NF-κB components not shown","Relationship to immunoglobulin-assembly role unclear"]},{"year":2024,"claim":"Implicated IGJ in inflammatory and proliferative signaling in rheumatoid arthritis synoviocytes, where knockdown suppresses growth, inflammation, motility, and NF-κB signaling.","evidence":"CCK-8, flow cytometry, ELISA, transwell, and immunoblot in MH7A cells","pmids":["39091178"],"confidence":"Low","gaps":["Pathway inference rests on western blot only without direct binding evidence","Opposite directionality of NF-κB effect versus breast cancer model unexplained"]},{"year":2025,"claim":"Linked IGJ to metabolic reprogramming and chemoresistance in B-ALL, where CRISPRa overexpression increases metabolic activity and confers resistance to several chemotherapeutics.","evidence":"CRISPRa overexpression, Seahorse metabolic assays, resazurin chemoresistance assays in NALM-6 cells","pmids":["41048199"],"confidence":"Low","gaps":["No pathway mechanism defined","Single gain-of-function experiment in one cell line"]},{"year":null,"claim":"How J-chain's intracellular immunoglobulin-assembly function relates mechanistically to its extracellular/regulatory roles in dendritic cell tolerance, T-cell help, and NF-κB-linked cancer phenotypes remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No molecular bridge identified between the assembly-factor and signaling/immunoregulatory activities","Direct binding partners outside the Ig polymer not characterized","Tissue-specific functions in non-B cells mechanistically undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,9,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,8]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,10,11]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,6]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,4,5]}],"complexes":["IgM pentamer","IgA dimer"],"partners":["ERP44","PU.1","EBF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P01591","full_name":"Immunoglobulin J chain","aliases":["Joining chain of multimeric IgA and IgM"],"length_aa":159,"mass_kda":18.1,"function":"Serves to link two monomer units of either IgM or IgA. In the case of IgM, the J chain-joined dimer is a nucleating unit for the IgM pentamer, and in the case of IgA it induces dimers and/or larger polymers. It also helps to bind these immunoglobulins to secretory component","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P01591/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/JCHAIN","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/JCHAIN","total_profiled":1310},"omim":[{"mim_id":"147790","title":"JOINING CHAIN OF MULTIMERIC IgA AND IgM; JCHAIN","url":"https://www.omim.org/entry/147790"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"breast","ntpm":2822.4},{"tissue":"intestine","ntpm":7466.4},{"tissue":"stomach 1","ntpm":5567.4}],"url":"https://www.proteinatlas.org/search/JCHAIN"},"hgnc":{"alias_symbol":["IGCJ","JCH"],"prev_symbol":["IGJ"]},"alphafold":{"accession":"P01591","domains":[{"cath_id":"-","chopping":"2-93","consensus_level":"high","plddt":86.2911,"start":2,"end":93},{"cath_id":"-","chopping":"127-159","consensus_level":"medium","plddt":93.0891,"start":127,"end":159}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P01591","model_url":"https://alphafold.ebi.ac.uk/files/AF-P01591-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P01591-F1-predicted_aligned_error_v6.png","plddt_mean":87.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=JCHAIN","jax_strain_url":"https://www.jax.org/strain/search?query=JCHAIN"},"sequence":{"accession":"P01591","fasta_url":"https://rest.uniprot.org/uniprotkb/P01591.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P01591/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P01591"}},"corpus_meta":[{"pmid":"8406004","id":"PMC_8406004","title":"Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8406004","citation_count":122,"is_preprint":false},{"pmid":"6417474","id":"PMC_6417474","title":"Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells.","date":"1983","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6417474","citation_count":84,"is_preprint":false},{"pmid":"6165077","id":"PMC_6165077","title":"Immunohistochemical evaluation of J-chain expression by intra- and extra-follicular immunoglobulin-producing human tonsillar cells.","date":"1981","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6165077","citation_count":53,"is_preprint":false},{"pmid":"2829207","id":"PMC_2829207","title":"Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2829207","citation_count":44,"is_preprint":false},{"pmid":"2452117","id":"PMC_2452117","title":"J-chain expression is more prominent in immunoglobulin A2 than in immunoglobulin A1 colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease.","date":"1988","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/2452117","citation_count":39,"is_preprint":false},{"pmid":"6417475","id":"PMC_6417475","title":"Biosynthesis of J-chain in human lymphoid cells producing immunoglobulins of various isotypes.","date":"1983","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6417475","citation_count":33,"is_preprint":false},{"pmid":"23897025","id":"PMC_23897025","title":"Noncoordinate expression of J-chain and Blimp-1 define nurse shark plasma cell populations during ontogeny.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23897025","citation_count":29,"is_preprint":false},{"pmid":"1631082","id":"PMC_1631082","title":"A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1631082","citation_count":27,"is_preprint":false},{"pmid":"27044543","id":"PMC_27044543","title":"High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27044543","citation_count":24,"is_preprint":false},{"pmid":"1735187","id":"PMC_1735187","title":"Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency.","date":"1992","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1735187","citation_count":24,"is_preprint":false},{"pmid":"12667685","id":"PMC_12667685","title":"Quantitative real-time RT-PCR measurement of mRNA encoding alpha-chain, pIgR and J-chain from canine duodenal mucosa.","date":"2003","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/12667685","citation_count":24,"is_preprint":false},{"pmid":"37539706","id":"PMC_37539706","title":"IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway.","date":"2023","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37539706","citation_count":21,"is_preprint":false},{"pmid":"10663570","id":"PMC_10663570","title":"Cloning and expression of the chicken immunoglobulin joining (J)-chain cDNA.","date":"2000","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10663570","citation_count":18,"is_preprint":false},{"pmid":"1763018","id":"PMC_1763018","title":"Interleukin 2- and interleukin 5-induced changes in the binding of regulatory factors to the J-chain gene promoter.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1763018","citation_count":18,"is_preprint":false},{"pmid":"18028376","id":"PMC_18028376","title":"A subset of dendritic cells express joining chain (J-chain) protein.","date":"2007","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18028376","citation_count":16,"is_preprint":false},{"pmid":"17015728","id":"PMC_17015728","title":"Stage-specific expression of two neighboring Crlz1 and IgJ genes during B cell development is regulated by their chromatin accessibility and histone acetylation.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17015728","citation_count":15,"is_preprint":false},{"pmid":"3025626","id":"PMC_3025626","title":"Accessibility of the promoter sequence in the J-chain gene is regulated by chromatin changes during B-cell differentiation.","date":"1986","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3025626","citation_count":13,"is_preprint":false},{"pmid":"6795716","id":"PMC_6795716","title":"Intestinal salivary, and tonsillar IgA and J-chain production in a patient with severe deficiency of serum IgA.","date":"1981","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/6795716","citation_count":13,"is_preprint":false},{"pmid":"18669274","id":"PMC_18669274","title":"[Problem of J-chain of immunoglobulins].","date":"2008","source":"Zhurnal evoliutsionnoi biokhimii i fiziologii","url":"https://pubmed.ncbi.nlm.nih.gov/18669274","citation_count":12,"is_preprint":false},{"pmid":"17936986","id":"PMC_17936986","title":"[Decrease in expression of human J-chain in lung squamous cell cancer and adenocarcinoma].","date":"2007","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/17936986","citation_count":11,"is_preprint":false},{"pmid":"3922629","id":"PMC_3922629","title":"J-chain expression in human cells producing IgG subclasses.","date":"1985","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3922629","citation_count":10,"is_preprint":false},{"pmid":"39632981","id":"PMC_39632981","title":"How J-chain ensures the assembly of immunoglobulin IgM pentamers.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/39632981","citation_count":9,"is_preprint":false},{"pmid":"27386924","id":"PMC_27386924","title":"Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-Chain.","date":"2016","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/27386924","citation_count":9,"is_preprint":false},{"pmid":"12389099","id":"PMC_12389099","title":"Cloning and expression of the turtle (Trachemys scripta) immunoglobulin joining (J)-chain cDNA.","date":"2002","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/12389099","citation_count":8,"is_preprint":false},{"pmid":"8235443","id":"PMC_8235443","title":"Characterization of the joining chain (J-chain) promoter.","date":"1993","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8235443","citation_count":8,"is_preprint":false},{"pmid":"38070292","id":"PMC_38070292","title":"Each N-glycan on human IgA and J-chain uniquely affects oligomericity and stability.","date":"2023","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/38070292","citation_count":7,"is_preprint":false},{"pmid":"16688681","id":"PMC_16688681","title":"Joining-chain (J-chain) negative mice are B cell memory deficient.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16688681","citation_count":7,"is_preprint":false},{"pmid":"4204602","id":"PMC_4204602","title":"Human J-chain: isolation and molecular weight studies.","date":"1974","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/4204602","citation_count":7,"is_preprint":false},{"pmid":"15691029","id":"PMC_15691029","title":"Measurement of messenger RNA encoding the alpha-chain, polymeric immunoglobulin receptor, and J-chain in duodenal mucosa from dogs with and without chronic diarrhea by use of quantitative real-time reverse transcription-polymerase chain reaction assays.","date":"2005","source":"American journal of veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/15691029","citation_count":6,"is_preprint":false},{"pmid":"16962668","id":"PMC_16962668","title":"The HSS3/4 enhancer of Crlz1-IgJ locus is another target of EBF in the pre-B cell stage of B cell development.","date":"2006","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/16962668","citation_count":4,"is_preprint":false},{"pmid":"16764696","id":"PMC_16764696","title":"Analysis of antigen-specific and naturally occurring IgM and IgA steady-state levels in J-chain negative C57BL/6 mice.","date":"2006","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16764696","citation_count":4,"is_preprint":false},{"pmid":"37871900","id":"PMC_37871900","title":"IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemia.","date":"2023","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/37871900","citation_count":3,"is_preprint":false},{"pmid":"16288984","id":"PMC_16288984","title":"A Stat5-overlapping site is critical for the IgJ enhancer activity in the plasma cells and bound by a ubiquitous protein.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16288984","citation_count":3,"is_preprint":false},{"pmid":"41333318","id":"PMC_41333318","title":"Jchain-diphtheria toxin receptor mice allow for depletion of antibody-secreting cells and analysis of differentiation kinetics.","date":"2025","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/41333318","citation_count":2,"is_preprint":false},{"pmid":"821533","id":"PMC_821533","title":"Localization of J-chain and interchain disulfide bonds in a human F(c)5mu-like fragment.","date":"1976","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/821533","citation_count":2,"is_preprint":false},{"pmid":"17065740","id":"PMC_17065740","title":"Recombinant human J-chain: fix the protein aggregations and yield maximize.","date":"2006","source":"Human antibodies","url":"https://pubmed.ncbi.nlm.nih.gov/17065740","citation_count":1,"is_preprint":false},{"pmid":"11953007","id":"PMC_11953007","title":"Cloning of the chicken immunoglobulin joining (J)-chain gene and characterization of its promoter region.","date":"2002","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11953007","citation_count":1,"is_preprint":false},{"pmid":"821482","id":"PMC_821482","title":"Studies on J-chain biosynthesis in tumours producing immunoglobulins in NZB mice.","date":"1976","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/821482","citation_count":1,"is_preprint":false},{"pmid":"39091178","id":"PMC_39091178","title":"IGJ depletion suppresses proliferation, inflammation, and motility of rheumatoid arthritis fibroblast-like synoviocytes via targeting NF-κB pathway.","date":"2024","source":"International journal of rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/39091178","citation_count":0,"is_preprint":false},{"pmid":"38766257","id":"PMC_38766257","title":"Jchain-Diphtheria Toxin Receptor Mice Allow for Diphtheria Toxin-Mediated Depletion of Antibody-Secreting Cells and Analysis of Differentiation Kinetics.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38766257","citation_count":0,"is_preprint":false},{"pmid":"41048199","id":"PMC_41048199","title":"Integration of Metabolic Profiling and Functional Genomics Suggests IGJ as a Driver of Chemoresistance in B-ALL.","date":"2025","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/41048199","citation_count":0,"is_preprint":false},{"pmid":"38106171","id":"PMC_38106171","title":"Temporal Tracking of Plasma Cells in vivo Using J-chain CreERT2 Reporter System.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38106171","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.03.611002","title":"IgSeqR: a protocol for the identification, assembly, and characterization of full-length tumor Immunoglobulin transcripts from unselected RNA sequencing data","date":"2024-09-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.03.611002","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21227,"output_tokens":4739,"usd":0.067383,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12947,"output_tokens":4729,"usd":0.09148,"stage2_stop_reason":"end_turn"},"total_usd":0.158863,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2024,\n      \"finding\": \"J-chain (JC) outcompetes the sixth IgM subunit during assembly of IgM pentamers. Before insertion into IgM, JC exists as largely unstructured, protease-sensitive species with heterogeneous non-native disulfide bonds. JC interacts with hydrophobic β-sheets selectively exposed by nascent pentamers, and completion of an amyloid-like core triggers JC folding and drives disulfide rearrangements that covalently stabilize JC-containing pentamers. The quality control factor ERp44 surveys IgM assembly and prevents secretion of aberrant conformers.\",\n      \"method\": \"In vitro reconstitution, in cellula assembly assays, protease sensitivity assays, disulfide bond analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution combined with in cellula validation and multiple orthogonal biochemical methods in a single rigorous study\",\n      \"pmids\": [\"39632981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The Ets-related transcription factor PU.1 is the nuclear protein (NF-JB) that mediates positive regulatory activity of the JB element in the J-chain promoter. PU.1 binds the JB site despite it lacking the canonical GGA Ets core, and a glutamine-rich sequence in the amino-terminal portion of PU.1 is required for transcriptional activation. A dominant negative PU.1 mutant suppresses transcriptional activity of a 1.2-kb J-chain promoter.\",\n      \"method\": \"Protein purification, DNA-binding characterization, transient transfection reporter assays, dominant-negative mutagenesis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — protein purification, functional mutagenesis, and reporter assays with multiple orthogonal methods in one study\",\n      \"pmids\": [\"8406004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"A bifunctional promoter element (JB, located between -75 and -45) in the J-chain gene acts as a repressor in J-chain-silent B cells and as an activator in J-chain-expressing cells. IL-2 signaling triggers the activator function of JB through a B-cell-specific nuclear protein NF-JB, making JB the likely target of the IL-2 signal.\",\n      \"method\": \"Deletion analysis of 5' flanking region, nuclear factor binding assays, transient transfection reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion mapping and factor binding combined, single lab, two orthogonal methods\",\n      \"pmids\": [\"1631082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"IL-2 and IL-5 each trigger a decrease in binding of two promoter-specific nuclear repressor proteins to the J-chain promoter, preceding the appearance of J-chain RNA. The two lymphokines act additively, their effects are reversed upon withdrawal, and both are inhibited by IL-4, indicating the IL-2 and IL-5 signal pathways converge to regulate repressor activities of J-chain promoter elements.\",\n      \"method\": \"Inducible β-lymphoma cell line, J-chain RNA expression analysis, nuclear factor binding assays, lymphokine withdrawal and IL-4 inhibition experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA expression and factor binding assays, single lab, two orthogonal methods\",\n      \"pmids\": [\"1763018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"Activation of the J-chain gene during B-cell differentiation to IgM-secreting cells is associated with chromatin remodeling at the 5' end of the gene: a 240-bp region is nuclease-resistant in immature B cells, becomes slightly more accessible in mature B cells, and displays an open DNase I-hypersensitive structure in IgM-secreting cells. This open structure is coinducible with J-chain gene expression in mitogen-stimulated lymphocytes.\",\n      \"method\": \"Nuclease sensitivity/DNase I hypersensitivity assays in lymphoid cell lines and mitogen-stimulated lymphocytes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chromatin accessibility assay combined with expression correlation, single lab\",\n      \"pmids\": [\"3025626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Stage-specific expression of the IgJ gene in plasma cells is regulated by chromatin accessibility and histone acetylation: hypersensitive site 1 on the IgJ promoter opens in plasma cells, and H3 and H4 histones at the IgJ gene chromatin are hyperacetylated in plasma cells but not in pre-B cells. IL-2 treatment of the BCL1 model cell line induces hyperacetylation of H3 and H4 at the IgJ gene chromatin.\",\n      \"method\": \"DNase I hypersensitivity mapping, chromatin immunoprecipitation for histone acetylation, IL-2 stimulation of BCL1 cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chromatin accessibility and ChIP assays, single lab, two orthogonal methods\",\n      \"pmids\": [\"17015728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The N459-glycan on the IgA1-Fc tailpiece is essential for dimer formation in the presence of J-chain (N459Q mutant fails to form proper dimer and instead generates higher-order aggregates). The N49-glycan on J-chain and the N263-glycan on IgA1-Fc both contribute to thermal stability of the Fc–J-chain complex. Fluorescence experiments indicate the N459-glycans cover a hydrophobic surface that prevents excess Fc molecules from approaching the dimeric IgA.\",\n      \"method\": \"Site-directed mutagenesis of N-glycosylation sites, mass spectrometry, fluorescence assays, thermofluor (thermal shift) assay, NMR of 13C-labeled Fc\",\n      \"journal\": \"Biochimica et biophysica acta. General subjects\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis, mass spectrometry, NMR, and functional thermal assays in one study, multiple orthogonal methods\",\n      \"pmids\": [\"38070292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"J-chain in IgA- and IgM-producing cells is substantially incorporated into polymeric Ig complexes at the cytoplasmic level; acid-urea pretreatment enhances J-chain staining, indicating molecular unfolding exposes concealed J-chains. The completed polymers bind secretory component (SC) in vitro via specific non-covalent forces at the cytoplasm of J-chain-positive IgA and IgM cells. IgM cells exhibit stronger SC binding than IgA cells. IgG and IgD cells do not generally express affinity for SC.\",\n      \"method\": \"Immunohistochemistry with acid-urea pretreatment, in vitro SC binding to tissue sections\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — IHC with functional SC-binding assay, replicated across multiple tissue types in one study\",\n      \"pmids\": [\"6417474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"In lymphoblastoid cell lines, J-chain is present in disulfide-linked form in IgM and IgA producers but in free (non-disulfide-linked) form in IgG cells; intracellular J-chain is not disulfide-linked to IgG in IgG/J-chain-producing cells. In PWM-stimulated PBL, J-chain is secreted only in disulfide-linked form associated with polymeric Ig and not as a free form. Subcellular fractionation showed J-chain and Ig associate with fractions containing ribosomes, cell sap, and low molecular weight RNA.\",\n      \"method\": \"Immunoprecipitation, immunofluorescence, RIA, subcellular fractionation, biosynthetic labeling\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical methods (fractionation, immunoprecipitation, biosynthetic labeling), single lab\",\n      \"pmids\": [\"6417475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1976,\n      \"finding\": \"Structural analysis of a human Fc5μ-like fragment showed that J-chain is covalently linked as a 'clasp' within a single IgM subunit (within the 95 kDa subunit) and not between two subunits, as determined by partial reduction, alkylation, and peptide sequence analysis.\",\n      \"method\": \"Partial reduction and alkylation, SDS-PAGE, peptide structural analysis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct biochemical structural determination but single study with limited follow-up in the corpus\",\n      \"pmids\": [\"821533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"J-chain protein is expressed in a subset of CD11c+ dendritic cells (DC) in mice. J-chain knockout mice have reduced fractions of CD4-/CD8α+ and mPDCA-1+ DC in the spleen, reduced IDO RNA in spleen, fewer IDO-expressing cells in lymph nodes, reduced IDO protein in splenic CD11c+ cells, lower serum kynurenine/tryptophan ratio (indicating reduced IDO activity), and are less susceptible to tolerance induction.\",\n      \"method\": \"Flow cytometry, J-chain knockout mice, IDO RNA and protein quantification, serum kynurenine/tryptophan ratio measurement, tolerance induction assays\",\n      \"journal\": \"Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — J-chain KO mouse with multiple functional readouts, single lab\",\n      \"pmids\": [\"18028376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"J-chain-deficient mice show normal primary IgG responses but compromised secondary IgG responses and reduced B cell repertoire switching from lambda to kappa. Adoptive transfer experiments demonstrated that the compromised secondary immune response is transferred with T cells from J-/- mice, establishing that J-chain deficiency causes a selective defect in T helper cell function that impairs B cell memory formation.\",\n      \"method\": \"J-chain knockout mice, immunization with NP-hapten, serum IgG measurement, B cell repertoire analysis, adoptive transfer experiments\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with adoptive transfer providing pathway placement, single lab\",\n      \"pmids\": [\"16688681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A Stat5-overlapping sequence in the IgJ enhancer is essential for enhancer function in plasma cells and is bound by a ubiquitous protein (not Stat5 or other tested Stat family members, <52 kDa), as identified by in vivo footprinting and EMSA. The opened chromatin of the IgJ enhancer is maintained in plasma cells even in the absence of IL-2/Stat5 signaling.\",\n      \"method\": \"In vivo footprinting, EMSA with competitors and antibodies, UV-crosslinking/SDS-PAGE, reporter assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — EMSA and in vivo footprint, identity of binding protein not determined, single lab\",\n      \"pmids\": [\"16288984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The HSS3/4 enhancer of the Crlz1-IgJ locus is bound by EBF (early B cell factor) specifically in pre-B cells, as shown by EMSA with oligo-DNA competitors, anti-EBF antibodies, and mutational analysis demonstrating that mutations within the EBF site impair HSS3/4 enhancer activity in pre-B cells but not in plasma cells.\",\n      \"method\": \"EMSA with competitors and anti-EBF antibodies, in vivo footprinting, enhancer reporter assay with EBF-site mutations\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA with antibody supershift and mutagenesis, two orthogonal methods, single lab\",\n      \"pmids\": [\"16962668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"IGJ overexpression in breast cancer cells suppresses proliferation, invasion, and metastasis in vivo and in vitro by inhibiting epithelial-to-mesenchymal transition (EMT) and suppressing nuclear translocation of p65 (NF-κB). Rescue experiments confirmed that IGJ restricts breast cancer cell proliferation and metastasis via the NF-κB signaling pathway.\",\n      \"method\": \"CCK-8 assay, invasion/migration assays, scratch tests, in vivo xenograft, western blot, immunofluorescence for p65 nuclear translocation, GSEA/KEGG analysis, rescue experiments\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — gain-of-function with multiple cellular readouts and pathway rescue, single lab\",\n      \"pmids\": [\"37539706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"IGJ knockdown in rheumatoid arthritis fibroblast-like synoviocytes (MH7A cells) inhibits cell growth, suppresses inflammatory response, and blocks cell motility. Mechanistically, IGJ knockdown suppresses the NF-κB signaling axis in these cells.\",\n      \"method\": \"CCK-8 and flow cytometry for growth, ELISA and immunoblot for inflammation, transwell assay for motility, immunoblot for NF-κB pathway components\",\n      \"journal\": \"International journal of rheumatic diseases\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, loss-of-function in a non-B-cell context with pathway inference by western blot only\",\n      \"pmids\": [\"39091178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"IGJ overexpression in NALM-6 B-ALL cells via CRISPRa leads to increased metabolic activity and confers resistance to dexamethasone, cytarabine, doxorubicin, and methotrexate but not cyclophosphamide, suggesting IGJ promotes metabolic reprogramming contributing to chemoresistance.\",\n      \"method\": \"CRISPRa-mediated IGJ overexpression, Seahorse XF metabolic assays, resazurin-based chemoresistance viability assays\",\n      \"journal\": \"Pediatric blood & cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single gain-of-function experiment in a cell line, no pathway mechanism defined, single lab\",\n      \"pmids\": [\"41048199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"J-chain expression during plasma cell differentiation is independent of immunoglobulin gene rearrangement status. EBV-transformed immunoglobulin-negative precursor B cells with no detectable Ig gene rearrangements still generate subpopulations producing high levels of J-chain, with J-chain production confined to cells that have exited the cell cycle to undergo plasma-cell differentiation.\",\n      \"method\": \"Immunoprecipitation after biosynthetic labeling, Northern blot hybridization, immunofluorescence, surface antigen analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (immunoprecipitation, Northern blot, immunofluorescence) in single lab study\",\n      \"pmids\": [\"2829207\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"JCHAIN encodes a ~15 kDa polypeptide that is incorporated into IgA dimers and IgM pentamers via disulfide bonds with the C-terminal tailpiece of α- or μ-heavy chains; mechanistically, it outcompetes the sixth IgM subunit during assembly by folding upon interaction with hydrophobic β-sheets of nascent pentamers and driving disulfide rearrangements, a process surveyed by ERp44; N-glycosylation of the IgA tailpiece (N459) and J-chain (N49) are required for proper dimer formation and complex stability; transcription of the JCHAIN gene is activated during B-cell differentiation by chromatin remodeling, histone hyperacetylation, and IL-2/IL-5 signaling acting through the JB promoter element whose positive activator is the Ets-family factor PU.1; beyond its immunoglobulin-assembly role, J-chain is expressed in a subset of immunoregulatory dendritic cells where it supports IDO activity and immune tolerance, and J-chain deficiency impairs T helper cell function and B-cell memory.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"JCHAIN encodes a small polypeptide that is incorporated into polymeric immunoglobulins, where it functions as an assembly factor that templates and stabilizes IgM pentamers and IgA dimers [#0, #6]. Mechanistically, J-chain begins as a largely unstructured, protease-sensitive species carrying heterogeneous non-native disulfide bonds; it engages hydrophobic \\u03b2-sheets selectively exposed on nascent IgM pentamers, and completion of an amyloid-like core triggers J-chain folding and drives the disulfide rearrangements that covalently lock it into the polymer in place of a sixth IgM subunit, a process surveyed by the quality-control factor ERp44 [#0]. Within IgM it is linked as a covalent 'clasp' inside a single subunit rather than bridging two subunits [#9], and it is incorporated only in disulfide-linked form in IgM- and IgA-producing cells while remaining free in IgG cells [#8]. N-glycosylation governs this assembly: the IgA1-Fc tailpiece N459-glycan is required for proper dimer formation and shields a hydrophobic surface that excludes excess Fc, while the J-chain N49- and Fc N263-glycans contribute thermal stability to the complex [#6]. Completed J-chain-containing polymers acquire the capacity to bind secretory component non-covalently, a property restricted to IgA and IgM cells [#7]. Transcription of JCHAIN is induced during terminal B-cell/plasma-cell differentiation, independent of immunoglobulin gene rearrangement [#17], through chromatin opening and histone H3/H4 hyperacetylation at the promoter [#4, #5] and through the bifunctional JB promoter element, whose IL-2/IL-5-driven activator function is mediated by the Ets-family factor PU.1 [#1, #2, #3]. Beyond immunoglobulin assembly, J-chain is expressed in a subset of CD11c+ dendritic cells where it supports IDO activity and tolerance induction [#10], and J-chain deficiency selectively impairs T helper cell function and secondary IgG/B-cell memory responses [#11].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1976,\n      \"claim\": \"Established the topology of J-chain within polymeric Ig by determining that it is covalently clasped inside a single IgM subunit rather than bridging adjacent subunits, constraining models of how J-chain organizes pentamer assembly.\",\n      \"evidence\": \"Partial reduction/alkylation and peptide structural analysis of a human Fc5\\u03bc-like fragment\",\n      \"pmids\": [\"821533\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not resolve how J-chain selects its insertion site during assembly\", \"Single structural study with limited follow-up\"]\n    },\n    {\n      \"year\": 1983,\n      \"claim\": \"Defined the assembly-state specificity of J-chain by showing it is disulfide-linked and secreted only with polymeric IgM/IgA and remains free in IgG cells, and that completed polymers acquire secretory-component binding.\",\n      \"evidence\": \"Immunoprecipitation, biosynthetic labeling, subcellular fractionation, and in vitro SC-binding to tissue sections\",\n      \"pmids\": [\"6417474\", \"6417475\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism distinguishing IgM/IgA from IgG incorporation not defined\", \"SC-binding assayed on tissue sections rather than purified components\"]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"Linked J-chain induction to chromatin remodeling by showing a 5' region transitions from nuclease-resistant in immature B cells to DNase I-hypersensitive in IgM-secreting cells, coinducible with expression.\",\n      \"evidence\": \"Nuclease/DNase I hypersensitivity assays in lymphoid lines and mitogen-stimulated lymphocytes\",\n      \"pmids\": [\"3025626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the trans-acting factors driving chromatin opening\", \"Correlative rather than causal link to expression\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Decoupled J-chain transcription from immunoglobulin gene rearrangement, showing that Ig-negative precursors lacking detectable rearrangements still produce high J-chain levels upon plasma-cell differentiation.\",\n      \"evidence\": \"Biosynthetic labeling/immunoprecipitation, Northern blot, immunofluorescence in EBV-transformed precursor B cells\",\n      \"pmids\": [\"2829207\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define the differentiation signal triggering expression\", \"Restricted to EBV-transformed lines\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identified the bifunctional JB promoter element as a repressor in silent cells and activator in expressing cells, and placed it downstream of IL-2 signaling via a B-cell-specific factor.\",\n      \"evidence\": \"Deletion mapping, nuclear factor binding, and reporter assays\",\n      \"pmids\": [\"1631082\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular identity of NF-JB not yet established\", \"Single-lab promoter dissection\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identified PU.1 as the NF-JB activator of the J-chain promoter, showing it binds the non-canonical JB site and that its glutamine-rich region and dominant-negative mutants control transcriptional output.\",\n      \"evidence\": \"Protein purification, DNA-binding characterization, reporter assays, dominant-negative mutagenesis\",\n      \"pmids\": [\"8406004\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain how PU.1 switches the element between repressor and activator modes\", \"Cofactors required for activation not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected stage-specific J-chain expression to histone hyperacetylation, showing H3/H4 acetylation and hypersensitive site opening occur in plasma cells and are inducible by IL-2.\",\n      \"evidence\": \"DNase I hypersensitivity mapping, ChIP for histone acetylation, IL-2 stimulation of BCL1 cells\",\n      \"pmids\": [\"17015728\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetyltransferases responsible not identified\", \"Causality between acetylation and transcription not directly tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Revealed non-immunoglobulin roles for J-chain in immunity, showing J-chain deficiency selectively impairs T helper function and secondary IgG memory responses via a T-cell-intrinsic defect.\",\n      \"evidence\": \"J-chain knockout mice, NP-hapten immunization, repertoire analysis, adoptive transfer\",\n      \"pmids\": [\"16688681\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the T-cell defect unknown\", \"Single-lab KO phenotype\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extended the regulatory map by identifying EBF binding at the HSS3/4 enhancer specifically in pre-B cells, with EBF-site mutations impairing enhancer activity in that stage.\",\n      \"evidence\": \"EMSA with anti-EBF supershift, in vivo footprinting, enhancer reporter mutagenesis\",\n      \"pmids\": [\"16962668\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of pre-B-cell enhancer activity in mature expression unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated a tolerogenic role for J-chain in dendritic cells, showing J-chain KO mice have reduced IDO-expressing DC subsets, lower IDO activity, and impaired tolerance induction.\",\n      \"evidence\": \"Flow cytometry, IDO RNA/protein quantification, serum kynurenine/tryptophan ratio, tolerance assays in J-chain KO mice\",\n      \"pmids\": [\"18028376\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular link between J-chain and IDO regulation not established\", \"Mechanism of J-chain action in DC unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined the glycan requirements for IgA dimer assembly, showing the Fc tailpiece N459-glycan is essential for proper dimerization and shields a hydrophobic surface that excludes excess Fc, with J-chain N49 and Fc N263 glycans stabilizing the complex.\",\n      \"evidence\": \"Site-directed mutagenesis, mass spectrometry, fluorescence, thermal shift, and NMR\",\n      \"pmids\": [\"38070292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Glycan contribution to IgM pentamer assembly not addressed\", \"In vivo relevance of aggregate formation untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved the mechanism of J-chain incorporation into IgM, showing unstructured J-chain folds upon engaging hydrophobic \\u03b2-sheets of nascent pentamers, completes an amyloid-like core, drives disulfide rearrangements, and outcompetes a sixth subunit under ERp44 surveillance.\",\n      \"evidence\": \"In vitro reconstitution, in cellula assembly assays, protease-sensitivity and disulfide analysis\",\n      \"pmids\": [\"39632981\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model of the folded J-chain/pentamer interface not fully defined\", \"How ERp44 distinguishes correct from aberrant conformers not detailed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Proposed a tumor-suppressive function for IGJ in breast cancer, where overexpression inhibits proliferation, invasion, EMT, and metastasis by blocking p65/NF-\\u03baB nuclear translocation.\",\n      \"evidence\": \"Proliferation/invasion assays, xenografts, western blot, p65 immunofluorescence, and rescue experiments\",\n      \"pmids\": [\"37539706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular interaction between IGJ and NF-\\u03baB components not shown\", \"Relationship to immunoglobulin-assembly role unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Implicated IGJ in inflammatory and proliferative signaling in rheumatoid arthritis synoviocytes, where knockdown suppresses growth, inflammation, motility, and NF-\\u03baB signaling.\",\n      \"evidence\": \"CCK-8, flow cytometry, ELISA, transwell, and immunoblot in MH7A cells\",\n      \"pmids\": [\"39091178\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Pathway inference rests on western blot only without direct binding evidence\", \"Opposite directionality of NF-\\u03baB effect versus breast cancer model unexplained\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linked IGJ to metabolic reprogramming and chemoresistance in B-ALL, where CRISPRa overexpression increases metabolic activity and confers resistance to several chemotherapeutics.\",\n      \"evidence\": \"CRISPRa overexpression, Seahorse metabolic assays, resazurin chemoresistance assays in NALM-6 cells\",\n      \"pmids\": [\"41048199\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No pathway mechanism defined\", \"Single gain-of-function experiment in one cell line\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How J-chain's intracellular immunoglobulin-assembly function relates mechanistically to its extracellular/regulatory roles in dendritic cell tolerance, T-cell help, and NF-\\u03baB-linked cancer phenotypes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No molecular bridge identified between the assembly-factor and signaling/immunoregulatory activities\", \"Direct binding partners outside the Ig polymer not characterized\", \"Tissue-specific functions in non-B cells mechanistically undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 9, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 8]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 10, 11]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 4, 5]}\n    ],\n    \"complexes\": [\"IgM pentamer\", \"IgA dimer\"],\n    \"partners\": [\"ERp44\", \"PU.1\", \"EBF1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}